Fenofibrate add-on therapy improves transplant-free survival in primary biliary cholangitis patients [0.03%]
苯扎贝特治疗可改善原发性胆汁性胆管炎患者的无移植生存率
Buer Li,Shuxiang Li,Sha Chen et al.
Buer Li et al.
Background: Fenofibrate has shown biochemical benefit in primary biliary cholangitis (PBC) patients with a suboptimal response to ursodeoxycholic acid (UDCA), but its long-term efficacy on survival remains unknown. ...
Fenofibrate add-on therapy improves transplant-free survival in primary biliary cholangitis patients [0.03%]
苯扎贝特对原发性胆汁性肝病患者生存率的影响研究
Buer Li,Shuxiang Li,Sha Chen et al.
Buer Li et al.
Background: Fenofibrate has shown biochemical benefit in primary biliary cholangitis (PBC) patients with a suboptimal response to ursodeoxycholic acid (UDCA), but its long-term efficacy on survival remains unknown. ...
Not every stomach is the same: tailoring dysplastic and early gastric cancer lesions detection [0.03%]
并非每个胃都一样：量身定制的胃病斑检测
Mariana Souto,Ana Isabel Ferreira,Tiago Lima Capela et al.
Mariana Souto et al.
Introduction: Early detection of gastric dysplastic lesions and early gastric cancer (EGC) is crucial to enable prompt treatments, such as endoscopic submucosal dissection (ESD). Understanding the distribution and charact...
Association of alcohol intake with pre-sarcopenia risk in steatotic liver disease: a dose-dependent relationship [0.03%]
饮酒与肝脂肪变性 sarcopenia 风险的剂量反应关系研究
Qiyang Chen,Ruifang Xu,Linxue Qian et al.
Qiyang Chen et al.
Objectives: An increased gradient of alcohol intake distinguished distinct clinical outcome risks across steatotic liver disease (SLD) subcategories, including metabolic dysfunction-associated steatotic liver disease (MAS...
Efficacy of molecular adsorbent recirculating system albumin dialysis in the treatment of hepatic encephalopathy associated with liver failure: a meta-analysis [0.03%]
分子吸附再循环系统白蛋白透析治疗肝衰竭相关性肝性脑病疗效的 Meta 分析
Weiying Xiang,Lei Zhang,Zhan Zhang
Weiying Xiang
This meta-analysis aimed to systematically evaluate the efficacy (including improvement of biochemical indicators and clinical outcomes) and safety of the molecular adsorbent recirculating system (MARS) in the treatment of hepatic encephalo...
Safety of percutaneous gastrostomy tube placement in patients with cirrhosis: a multicenter matched cohort study [0.03%]
经皮胃镜下胃肠造瘘术应用于肝硬化患者的安全性：多中心匹配队列研究
Mohamed H Eldesouki,Mohamed Elgozair,Omar Alkasabrah et al.
Mohamed H Eldesouki et al.
Background and aims: Patients with cirrhosis may require enteral access; however, the safety of percutaneous gastrostomy tube placement in this population remains unclear. We aimed to evaluate the safety of percutaneous g...
Letter to the editor regarding 'Correlation between infliximab trough levels and postoperative endoscopic recurrence in patients with Crohn's disease' [0.03%]
关于“英夫利西单抗谷浓度与克罗恩病患者术后内镜复发相关性”的来信
İbrahim Ethem Güven
İbrahim Ethem Güven
Appendicectomy in active ulcerative colitis: is the evidence strong enough to support clinical recommendation? A critical appraisal [0.03%]
溃疡性结肠炎发作期阑尾切除术的证据是否足以支持临床推荐？一次批判性评价
Bernardo de Faria Moraes,Leonardo Corrêa Süffert,Guilherme Grossi Lopes Cançado
Bernardo de Faria Moraes
Comment on 'The prognostic value of protein induced by vitamin K absence or antagonist-II in hepatocellular carcinoma patients undergoing surgical resection' [0.03%]
关于“维生素K缺乏或拮抗剂II诱导蛋白在肝细胞癌手术治疗患者中的预后价值”的评论
Kishankumar Mahida,Snehal Rajendra Jagtap
Kishankumar Mahida
Comment on 'Home-based transcutaneous electrical acupuncture-point stimulation for depressive symptoms in inflammatory bowel disease: a randomized feasibility study' [0.03%]
关于“炎症性肠病患者的居家穴位电刺激疗法改善抑郁症状可行性随机研究的述评”
Zilong Chen,Xiangrui Lin,Mingxian Chen
Zilong Chen